2015-2016 Annual Report
The HICOR team is committed to finding solutions to reduce the economic burden of cancer for patients, families and society. We view this critical issue through the lens of value — asking ourselves how our work can contribute to ensuring that patients receive the highest quality care and the best possible results without the financial devastation that too often accompanies a cancer diagnosis. We started with the simple yet vital concept of measurement. Could we gather and analyze the data necessary to create a picture of how cancer care is delivered in our community? The short answer, built on the hard work and expertise of our data and clinical analytics team, is yes.
Topics include cancer and bankruptcy, enhancing the impact of clinical trials, and economic perspectives on precision oncology.